Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV-infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine

1. Cid-Silva, P.
2. Fernández-Bargiela, N.
3. Margusino-Framiñán, L.
4. Balboa-Barreiro, V.
5. Mena-De-Cea, Á.
6. López-Calvo, S.
7. Vázquez-Rodríguez, P.
8. Martín-Herranz, I.
9. Míguez-Rey, E.
10. Poveda, E.
11. Castro-Iglesias, Á.